Germans Trias i Pujol Research Institute (IGTP)

🔵 An IGTP project led by Federico Fondelli, researcher in the Immunopathology Research Group, has been selected in the 2026 CaixaImpulse Health Innovation call by the Fundación ”la Caixa” and will receive €49,000. Current treatments for multiple sclerosis often rely on broader modulation or suppression of the immune response. Fondelli’s project explores a more targeted approach: retraining the immune response to restore tolerance to myelin. Using tolerogenic dendritic cells derived from the patient, the team generates regulatory T cells (Tregs) that specifically recognise myelin antigens. The project also incorporates tools to identify patients who may be more likely to respond to this strategy and to help predict the success of the cell production process. ➕ In addition, two other projects involving IGTP researchers have received funding through Fundación ”la Caixa” programmes in 2026: - Laura Fernández López (CEEISCAT-IGTP) leads a project on barriers to healthcare access among migrants, supported through the Connecta call. - Andreu Colom-Cadena (CEEISCAT-IGTP) participates in a collaborative study on hand hygiene in neonatal intensive care units, coordinated by IDIAPJGol (Institut d'Investigació en Atenció Primària de Salut Jordi Gol) and funded through the HealthCare Research Call. 🔗 Read more: https://lnkd.in/d6NnbhpE #FundlaCaixaResearch #FundlaCaixaResearchers #CaixaImpulse #MultipleSclerosis #CellTherapy #Immunology

Connecting research with people is central to GCAT - Genomes for life, one of IGTPs strategic research projects. Its new website reinforces this commitment by strengthening engagement with cohort participants, improving access to research information and resources, and fostering collaboration with the scientific community. Discover the new platform: https://lnkd.in/dqFjT94h

🟤 The CMCiB expands its rodent housing capacity and upgrades infrastructure for biomedical research The Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), a strategic project of IGTP, continues to strengthen its capacity to support biomedical research with the opening of a new rodent housing facility and the technological upgrading of animal housing systems in its conventional area. This initiative increases the centre’s capacity to support the research community, strengthens safety and biocontainment, improves animal welfare and enhances working conditions for biomedical research. The expansion also highlights the centre’s ability to adapt its facilities to evolving scientific needs while maintaining ongoing research activities throughout the works. 🔗 Read more: https://lnkd.in/ezYeEYPh #CMCiB #PreclinicalResearch #TranslationalResearch #AnimalWelfare #Biosafety

🎙️ When does emotional distress become a reason to seek professional help? In the latest episode of the podcast Un bri de ciència, psychiatrist Jorge Cuevas Esteban explores mental health beyond diagnoses: how to recognise when distress is interfering with everyday life, the persistence of stigma, and how psychiatric care is evolving towards more personalised and less restrictive models. Cuevas is head of the Adult Psychiatry Department at Hospital Universitari Germans Trias i Pujol, researcher of the Psychiatry and Mental Health Group at Germans Trias i Pujol Research Institute (IGTP), and associate professor at the Universitat Autònoma de Barcelona. He discusses what we mean by mental health, the signs that may indicate it is time to seek professional help, and the role of daily habits and our social environment. The conversation also looks at projects being carried out to improve psychiatric care. Un bri de ciència continues to bring science and health closer to the public, combining healthcare and research perspectives to explore topics that have a direct impact on people's lives. 🎧 Listen to the episode (in Catalan): https://lnkd.in/dQq2Y945 📰 Read more: https://lnkd.in/e9X5Ps9t #Outreach #Podcast #MentalHealth #WorldMentalHealthDay

🤝🏼 IGTP has welcomed a delegation of research organisations, universities and innovation stakeholders from Türkiye to explore new opportunities for international collaboration Today, researchers and professionals from the Germans Trias i Pujol Research Institute (IGTP) met with the delegation to share expertise, identify potential synergies and explore opportunities for future collaborations and international consortia. The program also included guided tours of the Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) facilities. The visit, facilitated by Leitat Technological Center, was part of a health-focused technical mission to Spain within the Technical Assistance for Türkiye in Horizon Europe project, supporting TÜBİTAK in strengthening connections with potential European partners and participation in EU Science, Research and Innovation projects. 🌍 An opportunity for IGTP to expand its international network and create new opportunities for European cooperation. 🔗 Read more: https://lnkd.in/e4SYw5he #IGTPInnovation #HorizonEurope #Research #Innovation #InternationalCollaboration TÜBİTAK Ufuk Avrupa Programı

How do the exposures we experience throughout our working lives interact with other factors that shape our health? GCAT - Genomes for life is participating in OMega-X (European Occupational Exposome Mega Cohort Consortium), a European resource bringing together 24 cohorts from eight countries and multinational studies, with data from more than 20 million participants. A new article in the International Journal of Epidemiology (Oxford University Press), co-authored by GCAT principal investigator de Cid Rafael, presents the consortium and its potential for occupational health and exposome research. GCAT contributes the perspective of a general population cohort from Catalonia, making it possible to study employment histories alongside environmental and lifestyle factors, clinical information and, in selected subgroups, molecular and multi-omics data. 💬 "OMega-X gives us the opportunity to connect occupational exposures with other dimensions of people’s lives and study their combined impact on health." - Natàlia Blay, GCAT researcher. This European collaboration will help explore how occupational exposures interact with other determinants of health across the life course. 🔗 Read more: https://lnkd.in/d-Teu4Ag #OccupationalHealth #Exposome #PublicHealth #Epidemiology

✅ The Glaucoma Unit at Hospital Universitari Germans Trias i Pujol has become the first in Catalonia -and the fifth in Spain- to receive the GlauCCare accreditation, recognising its standards of care, clinical outcomes and excellence in managing this highly complex condition.   Promoted and endorsed by the Sociedad Española de Glaucoma, GlauCCare establishes standards of excellence in glaucoma care.   The unit, led by Jordi Loscos Arenas, also combines  specialised care with research and innovation. In collaboration with Germans Trias i Pujol Research Institute (IGTP), it is studying tear fluid as a source of biomarkers and exploring its potential for diagnostic and and therapeutic applictions.   🔗 Read more: https://lnkd.in/dsfJBTux   #Glaucoma #Ophthalmology #Research #CampusCanRuti

🔵 A new strategic alliance is taking shape to strengthen comprehensive cancer care and research in northern Catalonia The ‘Consorci Oncològic Integral Nord Catalunya (NordCat-CCC)’ brings together the Institut Català d'Oncologia (ICO), Hospital Universitari Germans Trias i Pujol, Hospital Trueta, Josep Carreras Leukaemia Research Institute (IJC), Institut d'Investigació Biomèdica de Girona (IDIBGI) and the Germans Trias i Pujol Research Institute (IGTP). Together, the six institutions will integrate healthcare, research, innovation and training to serve nearly two million people across the Metropolitana Nord and Girona health regions. The initiative aims to achieve European certification as a Comprehensive Cancer Consortium and has already been selected as a pilot within the European Joint Action EUnetCCC - European Network of Comprehensive Cancer Centres.   For the IGTP, this alliance provides an opportunity to further strengthen translational cancer research and accelerate the transfer of scientific knowledge into clinical practice, contributing to more personalised, equitable and accessible cancer care. 🔗 Read more: https://lnkd.in/dqVJvW2C Joan Brunet Vidal, Ricard Mesia, Candela Calle, Jaume Heredia Quicios, Jordi Barretina, Ari Melnick, Marga Nadal #CancerResearch #Oncology #TranslationalResearch #CancerCare #NordCatCCC

🔬 ‘INTEGRA-DM1’, a comprehensive study of Myotonic Dystrophy type 1 to identify new biomarkers and advance precision medicine IGTP is taking part in this new multicentre project that aims to identify biomarkers to support the prevention and treatment of Myotonic Dystrophy type 1 (DM1), a rare genetic neuromuscular disease. ‘INTEGRA-DM1’ has received funding from the PINERA Rare Diseases Research Program of the Fundación Ramón Areces. The project is led by INCLIVA Instituto de Investigación Sanitaria, with the participation of and Medical Research Institute La Fe (IIS La Fe) and IGTP. The project builds on the collaboration and research developed through DM1-Hub, Spain’s first clinical registry for DM1, coordinated by Gisela Nogales Gadea, leader of IGTP’s Badalona Neuromuscular Research Group (GRENBA). 🔗 Read more: https://lnkd.in/eHDWFMxC #MyotonicDystrophy #MyotonicDystrophyAwareness #DM1 #RareDiseases #NeuromuscularDiseases #PrecisionMedicine

🔵 IGTP's 2025 Annual Report is now available! A particularly significant year for IGTP as we celebrated our 30th anniversary. The report looks back at three decades of research and innovation, while bringing together the main milestones that shaped 2025. The document, available as a full report and an executive summary, provides a snapshot of IGTP's activity: 1,110 scientific publications, 366 active projects, 986 active clinical studies, 101 events organised and 5 patents granted, among many other highlights. It also reflects continued progress across our strategic projects, scientific programs and core facilities. 👉🏼 Explore the 2025 Annual Report: https://lnkd.in/eivpSWzD 📰 Read the news story: https://lnkd.in/eNrMXV5i ICERCA - Centres de Recerca de Catalunya, Instituto de Salud Carlos III, Departament de Recerca i Universitats, Sistema de Salut de Catalunya